Skip to main content

Table 3 Effect of cisplatin (CP) and different treatments of AHE on lung tissue antioxidant enzymes

From: Correction to: Acacia hydaspica R. Parker ameliorates cisplatin induced oxidative stress, DNA damage and morphological alterations in rat pulmonary tissue

Group

POD

(U/min)

SOD

(U/mg protein)

CAT

(U/min)

QR

(nM/min/mg protein)

Control

9.56 ± 0.635b

1.366 ± 0.038b

18.48 ± 0.058b

128.2 ± 0.81b

CP

5.03 ± 0.271a

0.765 ± 0.019a

10.83 ± 0.049a

83.99 ± 0.486a

AHE alone

10.29 ± 0.314b

1.358 ± 0.058b

18.57 ± 0.057b

128.9 ± 0.179b

CP + AHE

6.22 ± 0.128a, d

0.982 ± 0.035a,b*,d**

14.15 ± 0.083a,b, d

98.82 ± 1.232a.b, d

AHE + CP

9.18 ± 0.185b, c

1.255 ± 0.038b,c**

17.07 ± 0.026a,b, c

119.5 ± 1.283a,b, c

CP + Sily

9.20 ± 0.208b

1.262 ± 0.021b

17.14 ± 0.081a,b

119.9 ± 1.008a,b

  1. Values expressed as mean ± SEM. a Significance at p < 0.0001 Vs. control group, b Significance at p < 0.0001 Vs. Cisplatin (CP) group. c Significance at p < 0.0001 of AHE + CP pre-treated group Vs. CP + AHE post-treated group. d Significance at p < 0.0001 of CP + AHE treatment groups Vs CP + Sily group. *, **: Significant difference at p < 0.001. Non-significant difference (p > 0.05) was recorded between control and AHE alone treated group in all parameters (One way ANOVA followed by Tukey’s multiple comparison tests)